Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant Activation of Cell-Cycle-Related Kinases and the Potential Therapeutic Impact of PLK1 or CHEK1 Inhibition in Uterine Leiomyosarcoma. | Clin Cancer Res | 2022 | 35302600 | PubTator, text mining | PubMed |
| The nuclease activity of DNA2 promotes exonuclease 1-independent mismatch repair. | J Biol Chem | 2022 | 35300981 | PubTator, text mining | PubMed |
| Upregulation of IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression That Is Related to Cell Proliferation, Metastasis and Tumor-Infiltrating Immune Cells. | Front Oncol | 2022 | 35299748 | PubTator, text mining | PubMed |
| Ribonucleotide Incorporation by Eukaryotic B-Family Replicases and Its Implications for Genome Stability. | Annu Rev Biochem | 2022 | 35287470 | PubTator, text mining | PubMed |
| Multi-phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations. | J Thromb Haemost | 2022 | 35285134 | PubTator, text mining | PubMed |
| Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer. | J Cancer | 2022 | 35281857 | PubTator, text mining | PubMed |
| Conformational Dynamics of DNA Polymerases Revealed at the Single-Molecule Level. | Front Mol Biosci | 2022 | 35281261 | PubTator, text mining | PubMed |
| Molecular Basis of Resveratrol-Induced Resensitization of Acquired Drug-Resistant Cancer Cells. | Nutrients | 2022 | 35277058 | PubTator, text mining | PubMed |
| An inductive graph neural network model for compound-protein interaction prediction based on a homogeneous graph. | Brief Bioinform | 2022 | 35275993 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Targeting of RecQ Helicases as a Novel Therapeutic Strategy for Ovarian Cancer. | Cancers (Basel) | 2022 | 35267530 | PubTator, text mining | PubMed |
| Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer Cells. | Cancers (Basel) | 2022 | 35267509 | PubTator, text mining | PubMed |
| Comprehensive Characterization of Ageing-Relevant Subtypes Associated With Different Tumorigenesis and Tumor Microenvironment in Prostate Cancer. | Front Mol Biosci | 2022 | 35265669 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| Label-free and homogeneous detection of flap endonuclease 1 by ligation-promoted hyperbranched rolling circle amplification platform. | Talanta | 2022 | 35255432 | PubTator, text mining | PubMed |
| Roles for the methyltransferase SETD8 in DNA damage repair. | Clin Epigenetics | 2022 | 35246238 | PubTator, text mining | PubMed |
| miR-4324 inhibits ovarian cancer progression by targeting FEN1. | J Ovarian Res | 2022 | 35246224 | PubTator, text mining | PubMed |
| A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases. | J Transl Autoimmun | 2022 | 35237749 | PubTator, text mining | PubMed |
| Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection. | Cell Rep Med | 2022 | 35233549 | PubTator, text mining | PubMed |
| XPG: a multitasking genome caretaker. | Cell Mol Life Sci | 2022 | 35230528 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=46